EVAR与开放腹主动脉瘤修复术后早期恢复质量的比较
前瞻性纳入141例择期肾下腹主动脉瘤修复患者(EVAR 62例,OSR 79例),用QoR-15问卷评估恢复质量。EVAR组出院时QoR-15评分较OSR组高10分(P=0.001),超过MCID 8分,但校正协变量后差异仍为10.0分(95%CI 1.6-18.4;P=0.020),至术后1个月差异消失(4分;P=0.135)。
要点
- EVAR组出院时QoR-15评分优于OSR组,差异超过MCID。
- 出院时优势经协变量校正后仍显著,但术后1个月消失。
- 患者报告的恢复质量可作为AAA修复的补充结局指标。
核心结论
- EVAR与出院时患者报告的恢复质量优势相关,该优势超过QoR-15的MCID,校正协变量后仍存在,但至术后1个月消失。
研究设计与样本
- 前瞻性队列研究,纳入2023年1月至2025年1月择期EVAR或OSR的肾下AAA患者141例(EVAR 62例,OSR 79例)。
- 采用线性混合效应模型分析QoR-15评分,并构建校正年龄、ASA≥3、缺血性心脏病、外周动脉疾病和高血压的二次模型。
主要发现
- QoR-15评分随时间显著变化(P<0.001),EVAR组总体评分更高(P=0.016)。
- 出院时组间差异为10分( favor EVAR,P=0.001),超过MCID 8分;基线差异2分(P=0.332),术后1个月差异4分(P=0.135),均低于MCID。
- 校正协变量后,出院时差异仍为10.0分(95%CI 1.6-18.4;P=0.020),平均组效应显著(F(1,131)=4.60;P=0.034)。
- 组×时间交互作用在未校正模型(P=0.052)和校正模型(P=0.101)中均不显著。
关键数值与推荐
- QoR-15的MCID为8分。
- 出院时EVAR组QoR-15评分较OSR组高10分(P=0.001),校正后差异10.0分(95%CI 1.6-18.4;P=0.020)。
临床怎么用
- 对于择期肾下AAA修复,EVAR可能改善出院时的患者报告恢复质量,可作为医患决策的补充信息。
- 术后1个月时恢复质量差异不明显,需关注出院后早期康复。
局限性
- 非随机设计,需更大样本研究确认。
- 单中心前瞻性队列,可能存在选择偏倚和未测量混杂。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To compare early postoperative quality of recovery after endovascular aortic repair (EVAR) versus open surgical repair (OSR) for infrarenal abdominal aortic aneurysm (AAA) using the Quality of Recovery-15 (QoR-15) questionnaire, interpreting between-group differences against the published minimal clinically important difference (MCID) for this instrument. METHODS: All patients undergoing elective EVAR or OSR between January 2023 and January 2025 were prospectively enrolled. QoR-15 was recorded at baseline, hospital discharge, and one month and analyzed with a linear mixed-effects model (group, time, and their interaction; random intercept per patient). Because the groups differed at baseline in several characteristics, a second, covariate-adjusted model added age, American Society of Anesthesiologists (ASA) class ≥3, history of ischemic heart disease, peripheral arterial disease, and hypertension as fixed effects. RESULTS: A total of 141 patients were analyzed (EVAR n = 62, OSR n = 79). Thirty-day mortality was 1.6% in the EVAR group and 0% in the OSR group. QoR-15 scores changed significantly over time (P < 0.001) and were higher overall in the EVAR group (P = 0.016). At discharge, the between-group difference was 10 points favoring EVAR (P = 0.001), exceeding the published MCID of 8 points and supporting clinical as well as statistical significance. This advantage was absent at baseline (2 points; P = 0.332) and at one month (4 points; P = 0.135), both below the MCID. After adjustment for age, ASA class, ischemic heart disease, peripheral arterial disease, and hypertension, the discharge difference remained unchanged (10.0 points, 95% confidence interval: 1.6-18.4; P = 0.020), and the averaged group effect stayed significant (F (1,131) = 4.60; P = 0.034). The group × time interaction was nonsignificant in both models (unadjusted P = 0.052; adjusted P = 0.101). CONCLUSION: EVAR was associated with a discharge-time advantage in patient-reported recovery that exceeded the MCID for QoR-15, and this advantage persisted after covariate adjustment but resolved by one month. These findings support patient-reported recovery as a clinically meaningful complementary outcome after AAA repair, although the nonrandomized design warrants confirmation in a larger study.
引用
- Hostalrich A, Boisroux T, Pinelli V, et al. Early Quality of Recovery after Endovascular Versus Open Abdominal Aortic Aneurysm Repair. Ann Vasc Surg. 2026. PMID: 42759932. doi:10.1016/j.avsg.2026.09.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。